SEPTIN9 gene methylation (SEPT9m) is an epigenetic phenomenon that occurs during CRC tumorigenesis and a well-demonstrated biomarker in plasma for screening and early diagnosis of CRC [5]. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.